A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/1998
10/21/1998	CN1040326C Preparation method of imidazopyridine PAF/H1 antagonists
10/20/1998	US5824839 Delivery of gene products via mesangial cells
10/20/1998	US5824805 Branched hydrazone linkers
10/20/1998	US5824784 Genetic engineering with polypeptides and proteins
10/20/1998	US5824776 Cell-targeted lytic pore-forming agents
10/20/1998	US5824696 Medicaments
10/20/1998	US5824681 Immunomodulating effect
10/20/1998	US5824673 Pharmaceutical compositions comprising metal complexes
10/20/1998	US5824652 Heterocyclic acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same
10/20/1998	US5824504 Polynucleotides
10/20/1998	US5824304 Peripheralization of hematopoietic stem cells
10/15/1998	WO1998045712A2 20 human secreted proteins
10/15/1998	WO1998045711A2 Assay for ligands to tyrosine kinase receptors
10/15/1998	WO1998045444A1 Vaccines with enhanced intracellular processing
10/15/1998	WO1998045441A1 Human gtp binding protein
10/15/1998	WO1998045330A1 Antiviral protease inhibitors
10/15/1998	WO1998045325A1 Peptides useful for reducing symptoms of toxic shock syndrome
10/15/1998	WO1998045323A1 Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses
10/15/1998	WO1998045278A1 Asymmetric synthesis of benzoxazinones via new intermediates
10/15/1998	WO1998045275A1 Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity
10/15/1998	WO1998045269A1 Quinoline derivatives, having in particular antiviral properties, preparation and biological applications thereof
10/15/1998	WO1998045268A1 Nicotinamide derivatives
10/15/1998	WO1998045249A1 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same
10/15/1998	WO1998044947A1 Allergen formulation
10/15/1998	WO1998044940A1 Use of lactoferin in the treatment of allergen induced disorders
10/15/1998	WO1998044919A1 Use of aminothiolester derivatives in pharmaceutics
10/15/1998	WO1998044913A2 Compositions containing mkc-442 in combination with other antiviral agents
10/15/1998	WO1998030589A3 Secreted proteins and polynucleotides encoding them
10/15/1998	WO1998017810A3 Multi-functional chimeric hematopoietic receptor agonists
10/15/1998	CA2286346A1 Peptides useful for reducing symptoms of toxic shock syndrome
10/15/1998	CA2286303A1 20 human secreted proteins
10/15/1998	CA2286283A1 Human gtp binding protein
10/15/1998	CA2285960A1 Use of lactoferin in the treatment of allergen induced disorders
10/15/1998	CA2285933A1 Assay for ligands to tyrosine kinase receptors
10/15/1998	CA2285577A1 Compositions containing mkc-442 in combination with other antiviral agents
10/15/1998	CA2285454A1 Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity
10/15/1998	CA2285287A1 Antiviral protease inhibitors
10/15/1998	CA2285000A1 Asymmetric synthesis of benzoxazinones via new intermediates
10/14/1998	EP0870827A2 Tumor necrosis factor related receptor, TR6
10/14/1998	EP0870825A1 Human protein kinases hYAK3
10/14/1998	EP0870508A1 Influenza vaccine
10/14/1998	EP0870049A2 Complementary adenoviral vector systems and cell lines
10/14/1998	EP0870038A1 INTERLEUKIN-1$g(b) CONVERTING ENZYME LIKE CYSTEINE PROTEASE
10/14/1998	EP0870034A1 Novel nagpu
10/14/1998	EP0870028A1 Nucleic acids encoding interferon gamma inducing factor-2
10/14/1998	EP0870022A1 Immunostimulatory composition and method
10/14/1998	EP0870019A2 Cell activation process and reagents therefor
10/14/1998	EP0869972A1 Chemokine from niddm pancreas
10/14/1998	EP0869967A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
10/14/1998	EP0869955A1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
10/14/1998	EP0869945A1 Catechol diethers derivatives useful as pharmaceutical agents
10/14/1998	EP0869810A1 Cyclosporin-containing soft capsule preparations
10/14/1998	EP0869809A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
10/14/1998	EP0869801A2 Therapeutic and diagnostic agents for the treatment of microbial infections
10/14/1998	EP0869782A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RAR $g(a)? RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY
10/14/1998	EP0764273B1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
10/14/1998	EP0755380B1 15-deoxyspergualin analogs, therapeutical use thereof, and method for preparing same
10/14/1998	CN1040178C Complement inhibitor for preparing drug for promoting transplantation survival or eliminating rejection
10/13/1998	US5821366 1,3-disubsituted-zanthines to treat diseases associated with proteins that mediate cellular activity
10/13/1998	US5821332 Isolated receptor polypeptide having specified amino acid sequence; modulating immune response
10/13/1998	US5821267 Modulating the inducible isoform over the constitutive; hypertensive, antiarthritic and diabetic agents; therapy with cytokines; toxic and septic shock
10/13/1998	US5821264 Used in foodstuffs and dietary supplements to decrease lipoprotein concentration or increase feed conversion
10/13/1998	US5821262 Hydroxamic acid derivatives as inhibitors of cytokine production
10/13/1998	US5821255 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
10/13/1998	US5821240 Pyrimido 5,4!-dipyrimidines, pharmaceuticals containing them, their use and processes for the preparation thereof
10/13/1998	US5821227 Modulators of cytokines of the tgf β superfamily
10/13/1998	US5821123 Modified antibody variable domains
10/13/1998	US5821122 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
10/13/1998	US5821117 Porcine cell comprising alpa-1,3 galactosyl transferase
10/13/1998	US5821071 By introducing a nucleotide sequence encoding a syk gene; gene expression; phosphorylation of fc-gamma receptors; for combatting infections
10/13/1998	US5820872 Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor
10/13/1998	US5820866 Product and process for T cell regulation
10/13/1998	US5820862 T cell epitopes of the major allergens from dermatophagoides (house dust mite)
10/08/1998	WO1998044129A1 Enhancement of immune response using targeting molecules
10/08/1998	WO1998044118A1 Chemokine beta-6
10/08/1998	WO1998043982A1 Tetracyclical derivatives from pyrimidine
10/08/1998	WO1998043971A1 Novel pyridine derivatives and pharmaceutical compositions containing them
10/08/1998	WO1998043969A1 Indazoles of cyclic ureas useful as hiv protease inhibitors
10/08/1998	WO1998043959A1 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
10/08/1998	WO1998043657A2 Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same
10/08/1998	WO1998043640A1 Benzocycloheptathiophene compounds
10/08/1998	WO1998043623A1 Antirheumatic agents
10/08/1998	WO1998043482A1 Fibrocyte-based cellular therapy formulations
10/08/1998	DE19714913A1 Patient-specific immune adsorber
10/08/1998	CA2287298A1 Tetracyclical derivatives from pyrimidine
10/08/1998	CA2285692A1 Enhancement of immune response using targeting molecules
10/08/1998	CA2285622A1 Chemokine beta-6
10/08/1998	CA2285215A1 Antirheumatic agents
10/08/1998	CA2284597A1 Novel pyridine derivatives and pharmaceutical compositions containing them
10/08/1998	CA2284471A1 Fibrocyte-based cellular therapy formulations
10/08/1998	CA2282593A1 Indazoles of cyclic ureas useful as hiv protease inhibitors
10/07/1998	EP0869180A1 A TNF homologue, TL5
10/07/1998	EP0869179A1 Tumor necrosis related receptor, TR7
10/07/1998	EP0869178A1 SAF-3, Sialoadhesin family member-3
10/07/1998	EP0868918A2 Vaccines
10/07/1998	EP0868917A1 Use of stevia extracts for the manufacture of an antihistaminic composition
10/07/1998	EP0868911A2 Rapamycin formulations for oral administration
10/07/1998	EP0868536A1 Genetic suppressor elements against human immunodeficiency virus
10/07/1998	EP0868522A1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
10/07/1998	EP0868430A1 Therapeutic compositions

1 ... 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 ... 1172